26 results
8-K
EX-99.1
o0xhui3vz r5bp8u7omr
17 Feb 21
Hepion Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
8:06am
8-K
zdt c322q
10 Jun 20
Hepion Pharmaceuticals Welcomes Industry Veteran and Drug Development Expert, Dr. Peter Wijngaard, to its Board of Directors
5:04pm
10-KT
27tmmzs1mcc2u2o5msv
26 Mar 18
Annual report (with FYE transition)
12:00am
424B5
0aq86sgtu1v19gw
7 Oct 15
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
177czlih
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am
DEF 14A
vfl9j924 3cju1xhwv4q
27 Oct 14
Definitive proxy
12:00am
PRER14A
gd2xrg81
23 Oct 14
Preliminary revised proxy
12:00am
10-K
iokliagep gk5hdoryvj
29 Sep 14
Annual report
12:00am